Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan.
Chih-Ming LiangWei-Chen TaiPin-I HsuDeng-Chyang WuChao-Hung KuoFeng-Woey TsayChia-Long LeeKuan-Yang ChenSeng-Kee ChuahPublished in: Therapeutic advances in gastroenterology (2020)
Primary, secondary and tertiary antibiotic resistance to clarithromycin, levofloxacin and metronidazole for H. pylori has been increasing in Taiwan since 2013. Treatment should be targeted for eradication success rates of more than 90%. Third-line treatment should be based on antibiotic susceptibility.